A 57-Week, Multicenter, Active-treatment, Open-label Extension Trial of CVL-865 as Adjunctive Therapy in Adults with Drug-Resistant Focal Onset Seizures.

  • O'Brien, Terence (Primary Chief Investigator (PCI))
  • Nicolo, John-Paul (Chief Investigator (CI))
  • Nikpour, Armin (Chief Investigator (CI))
  • Wijayath, Manori (Chief Investigator (CI))
  • D'Souza, Wendyl Jude (Chief Investigator (CI))
  • Reutens, David C. (Chief Investigator (CI))
  • Carney, Patrick (Chief Investigator (CI))
  • Somerville, Ernest Robertson (Chief Investigator (CI))
  • Mullen, Saul Alator (Chief Investigator (CI))
  • Frasca, Joseph (Chief Investigator (CI))

Project: Research

Project Details

Effective start/end date18/12/2031/12/24


  • Epilepsy
  • Seizures
  • Clinical trial